highly significantp < 0.0001
Test Treatment C demonstrated highly significant increases of 17.48 ± 1.79 or 34.85% (p < 0.0001) at day 30 when compared to the baseline and 22.42 ± 9.1 or 73.67% (p < 0.0001) at day 90.
Test Treatment C demonstrated highly significant increases of 17.48 ± 1.79 or 34.85% (p < 0.0001) at day 30 when compared to the baseline and 22.42 ± 9.1 or 73.67% (p < 0.0001) at day 90.